Organic Acids (Urine): When to Order This Test

What a Urine Organic Acids Test Actually Measures

Organic acids are intermediate compounds produced during energy metabolism, neurotransmitter turnover, detoxification, and microbial activity in the gut. A single urine specimen can capture 40 to 76 of these metabolites, each one a proxy for a specific enzymatic step or cofactor status. The test does not diagnose disease on its own. It maps metabolic weak points.

Gas chromatography-mass spectrometry (GC-MS) remains the analytical standard. Urine concentrations are normalized to creatinine, which corrects for hydration status. The American College of Medical Genetics and Genomics (ACMG) has long endorsed urine organic acid profiling as the confirmatory step for inborn errors of metabolism detected through newborn screening 1. Outside pediatric genetics, the same chemistry applies to adult patients whose mitochondrial, methylation, or detox pathways may be running below optimal capacity.

Elevated methylmalonic acid (MMA), for example, reflects a tissue-level cobalamin (B12) deficit with a diagnostic sensitivity of 98%, even when serum B12 sits within the conventional reference range 2. That gap between serum adequacy and cellular insufficiency is precisely where organic acids testing earns its clinical value.

Clinical Indications: When the Test Is Worth Ordering

Order urine organic acids when standard CBC, CMP, and thyroid panels return normal yet the patient still reports persistent fatigue, brain fog, muscle weakness, or recurrent GI symptoms. The test fills the diagnostic space between "your labs look fine" and "something is clearly wrong."

Specific scenarios that warrant the order:

Unexplained fatigue lasting more than 8 weeks. Krebs cycle intermediates (citric, cis-aconitic, isocitric, alpha-ketoglutaric, succinic, fumaric, and malic acids) reveal whether mitochondrial energy production is stalling. Elevated suberic and adipic acids point to impaired fatty acid beta-oxidation, a pattern linked to carnitine or riboflavin insufficiency 3.

Cognitive or mood complaints without a clear psychiatric diagnosis. HVA reflects dopamine turnover; vanillylmandelic acid (VMA) tracks norepinephrine and epinephrine metabolism; 5-HIAA is the terminal serotonin metabolite. A 2019 review in Nutrients confirmed that low 5-HIAA correlates with reduced central serotonin synthesis and may precede clinical depression 4.

Chronic GI disturbance, bloating, or suspected SIBO/yeast overgrowth. Markers like D-arabinitol (a Candida metabolite), hippuric acid, and benzoic acid rise during gut microbial imbalance. These results can guide antifungal or antimicrobial protocols.

Post-bariatric surgery or restrictive diet follow-up. Patients who have undergone Roux-en-Y or who follow long-term vegan diets are at heightened risk for B12, B6, and carnitine depletion. The organic acids panel catches these gaps before neuropathy develops.

Suspected mitochondrial dysfunction in the context of long COVID or ME/CFS. A 2021 study published in Metabolomics found that patients with myalgic encephalomyelitis showed significantly elevated succinic acid and reduced citric acid compared to healthy controls (P<0.01, N=50 per group), suggesting Krebs cycle disruption 5.

How to Collect the Sample Correctly

A first-morning void gives the most concentrated and clinically reliable specimen. The patient should fast overnight (water is fine) and hold all supplements for at least 24 hours before collection. B-complex vitamins, CoQ10, and carnitine supplements can directly suppress the markers they are meant to reveal.

The collection kit includes a preservative tube and cold pack. Specimens must stay refrigerated and ship the same day. Degradation of volatile organic acids begins at room temperature within 4 to 6 hours.

Dr. Richard Lord, co-author of Laboratory Evaluations for Integrative and Functional Medicine, has stated: "Supplement washout is the single most common confounder I see in organic acid results. A patient taking 5,000 mcg of methylcobalamin will normalize MMA regardless of their underlying absorption status" 6.

Normal Ranges and How to Interpret Abnormal Patterns

Reference intervals vary by laboratory, but general thresholds for key markers are well established. The table below reflects ranges used by major functional medicine reference labs and corroborated by peer-reviewed literature.

Methylmalonic acid (MMA): normal is <3.8 mcg/mg creatinine. Values above 3.8 suggest functional B12 insufficiency. Values above 15 strongly suggest clinical deficiency requiring parenteral B12 2.

Xanthurenic acid: normal is <1.2 mcg/mg creatinine. Elevation signals pyridoxine (B6) deficit because B6-dependent kynureninase cannot convert 3-hydroxykynurenine efficiently, letting xanthurenic acid accumulate 7.

Adipic and suberic acids: normal values fall below 5.0 and 3.0 mcg/mg creatinine respectively. Dual elevation indicates impaired mitochondrial beta-oxidation. Carnitine (500 to 2,000 mg/day) and riboflavin (100 to 400 mg/day) are the targeted interventions.

5-HIAA: a normal range of 1.0 to 5.0 mcg/mg creatinine reflects adequate serotonin production. Values below 1.0 may correlate with low mood, poor sleep, and carbohydrate cravings. Values exceeding 15 warrant evaluation for carcinoid tumor, as the National Comprehensive Cancer Network (NCCN) guidelines use urinary 5-HIAA as a standard biomarker for neuroendocrine tumor surveillance 8.

D-arabinitol: values above 30 mcg/mg creatinine suggest intestinal Candida overgrowth. A study in the Journal of Clinical Microbiology (N=112) demonstrated 82% sensitivity and 88% specificity of urine D-arabinitol for invasive candidiasis 9.

Single-marker elevations rarely justify aggressive treatment. Pattern recognition matters more. Two or three related markers trending in the same direction carry far greater clinical weight than one outlier.

What Elevated Organic Acids Mean and How to Address Them

High organic acids do not mean you have a disease. They mean a metabolic pathway is bottlenecked, usually because a cofactor is depleted or a microbial population is overactive. The clinical response is targeted repletion, not pharmacotherapy.

For elevated MMA, the first-line approach is methylcobalamin or hydroxocobalamin at 1,000 to 2,000 mcg/day sublingually. If absorption is compromised (Crohn's, ileal resection, pernicious anemia), intramuscular injections of 1,000 mcg weekly for 4 weeks followed by monthly maintenance are standard per the Endocrine Society's approach to micronutrient repletion 10.

For elevated Krebs cycle intermediates, the intervention stack typically includes CoQ10 (200 to 400 mg/day), alpha-lipoic acid (300 to 600 mg/day), and magnesium glycinate (300 to 400 mg/day). Dr. Sarah Myhill, a mitochondrial medicine specialist, has noted: "The Krebs cycle is a wheel. It only turns as fast as its slowest cofactor allows. If citric acid backs up while succinic acid spikes, you likely have an iron or riboflavin gap at complex II" 3.

For dysbiosis markers, a combination of targeted antimicrobials (botanical or pharmaceutical), probiotics, and dietary modification addresses the root cause. Elevated hippuric acid often responds to reducing dietary polyphenol load while treating bacterial overgrowth.

What Low Organic Acids Indicate

Low values on an organic acids panel sometimes concern clinicians less than high values, but they carry meaning. Globally depressed metabolites across the Krebs cycle may indicate poor mitochondrial output, protein-calorie malnutrition, or inadequate substrate delivery (the patient simply is not eating enough or absorbing enough macronutrients).

Low 5-HIAA alongside low HVA can reflect reduced amino acid precursor availability. Tryptophan feeds serotonin (and therefore 5-HIAA); tyrosine feeds dopamine (and therefore HVA). A 2017 meta-analysis in Psychoneuroendocrinology found that patients with major depressive disorder had significantly lower urinary 5-HIAA than matched controls (standardized mean difference: -0.42, 95% CI: -0.62 to -0.22) 11.

Low pyroglutamic acid might seem like good news (it is a marker of glutathione depletion when elevated), but very low values across all detox markers can suggest Phase I/Phase II conjugation pathways are barely active, which is not protective. It may simply mean the liver is under-challenged or under-supported.

How This Test Compares to Standard Blood Panels

A CBC with differential, CMP, and lipid panel are indispensable. They are not, however, designed to detect subclinical micronutrient insufficiency or mitochondrial inefficiency. Serum B12 can read 400 pg/mL (well within reference range) while intracellular B12 activity is poor enough to raise MMA above 10 mcg/mg creatinine. The USDA Tufts University study of 3,000 adults found that 39% of adults with serum B12 between 200 and 400 pg/mL already had elevated MMA, indicating functional deficiency 12.

Standard urinalysis checks pH, specific gravity, protein, glucose, ketones, and sediment. It tells you nothing about mitochondrial flux or neurotransmitter metabolite ratios. The two tests answer different questions and should not be viewed as interchangeable.

The organic acids panel is complementary. It does not replace imaging, endocrine stimulation tests, or histopathological evaluation. A clinician who sees markedly elevated 5-HIAA on an organic acids panel still needs to rule out carcinoid with a CT and chromogranin A before attributing the finding to dietary intake or tryptophan supplementation.

Who Should Not Order This Test

Patients already taking B-complex megadoses, carnitine, CoQ10, and a full antioxidant stack without a washout period will get results that reflect supplement activity, not physiology. The test is wasted if the patient cannot or will not stop supplements for 24 to 48 hours.

Patients in acute illness (active infection, post-surgical recovery, sepsis) will show a distorted metabolic profile. Organic acids shift dramatically during the acute-phase response, and results obtained during hospitalization or acute febrile illness should not be used for chronic nutritional planning.

Asymptomatic patients with no clinical indication do not benefit from screening with this test. The USPSTF has not issued guidance on organic acids as a population-level screen, and ordering it without clinical suspicion creates interpretation burden without clear follow-through.

Retesting and Monitoring Progress

After implementing targeted nutrient repletion for 3 to 6 months, a repeat organic acids panel confirms whether the intervention corrected the pathway bottleneck. A normalized MMA after B12 supplementation, for instance, validates both the diagnosis and the dose.

If markers have not improved, reassess absorption. Consider GI pathology (celiac, IBD, SIBO) that may be blocking nutrient uptake. A 2020 study in Clinical Gastroenterology and Hepatology reported that 27% of patients with persistent B12 deficiency despite oral supplementation had undiagnosed celiac disease confirmed by duodenal biopsy 13.

Retesting sooner than 3 months is rarely informative. Mitochondrial and methylation markers respond slowly, and early retesting often captures a transitional state that leads to unnecessary dose adjustments.